Content about Pneumonia

December 18, 2013

Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced,

MARSHFIELD, Wis. — Respiratory Syncytial Virus appears to cause milder illness than influenza in adults age 50 or older, researchers at Marshfield Clinic Research Foundation announced Wednesday.

The study, published online in Clinical Infectious Diseases, also shows RSV is a common cause of respiratory illness in older adults and that the chance of infection increases with age.

May 22, 2013

A new vaccine against pneumococcal disease appears as safe as an older one, according to a new study.

PASADENA, Calif. — A new vaccine against pneumococcal disease appears as safe as an older one, according to a new study.

The study, conducted by Kaiser Permanente and published Wednesday in the journal Vaccine, compared the new 13-valent vaccine with the seven-valent one used before 2010. The Food and Drug Administration approved the newer vaccine, called PCV13, in 2010 after a series of trials. The valent number refers to the number of varieties of pneumococcal disease the vaccine prevents.

February 26, 2013

A Virginia-based pharmacy school will collaborate with an alliance of more than 22,000 pharmacies around the country to find ways to promote and increase pneumococcal vaccinations among elderly and high-risk people.

LEESBURG, Va. — A Virginia-based pharmacy school will collaborate with an alliance of more than 22,000 pharmacies around the country to find ways to promote and increase pneumococcal vaccinations among elderly and high-risk people.

January 28, 2013

The Food and Drug Administration has approved a new use for a pneumococcal vaccine made by Pfizer, the drug maker said.

NEW YORK — The Food and Drug Administration has approved a new use for a pneumococcal vaccine made by Pfizer, the drug maker said.

Pfizer announced the approval of Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) for children and adolescents ages 6 years to 17 years for active immunization against the 13 Streptococcus pneumonia serotypes the vaccine covers. For this group, Prevnar 13 is administered as a one-time dose to patients who have never received it.

August 16, 2012

Pharmaca Integrative Pharmacy on Tuesday announced that it now is offering immunizations for influenza, whooping cough, pneumonia and shingles on a walk-in basis at all of its locations.

BOULDER, Colo. — Pharmaca Integrative Pharmacy on Tuesday announced that it now is offering immunizations for influenza, whooping cough, pneumonia and shingles on a walk-in basis at all of its locations. Pharmaca pharmacists can provide the shots to any customer who requests one during open pharmacy hours.
 

June 15, 2012

GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

PHILADELPHIA — GlaxoSmithKline has received regulatory approval from the Food and Drug Administration for a vaccine designed to prevent invasive disease caused by Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B.

MenHibrix (Meningococcal Groups C and Y and Haemophilus b Tetanus Toxoid conjugate vaccine) is approved for use in children ages six weeks through 18 months. The vaccination schedule is a four-dose series given at two, four, six, and 12 through 15 months of age.

January 26, 2012

Pharmacists in Florida are hoping to expand the kinds of vaccinations they can administer, according to published reports.

NEW YORK — Pharmacists in Florida are hoping to expand the kinds of vaccinations they can administer, according to published reports.

Tallahassee, Fla., CBS affiliate WTSP reported that a bill proposed in the state legislature would allow pharmacists to administer shots to prevent pneumonia and shingles. While pharmacists in Florida have been able to administer flu shots since 2007, the state remains one of the few where they can't administer pneumonia and shingles shots.

A committee in the state House of Representatives voted in favor of the bill, WTSP reported.

January 3, 2012

The Food and Drug Administration has approved a Pfizer vaccine for Streptococcus pneumoniae in adults ages 50 years and older, the company said.

NEW YORK — The Food and Drug Administration has approved a Pfizer vaccine for Streptococcus pneumoniae in adults ages 50 years and older, the company said.

Pfizer announced the FDA approval of Prevnar 13 (pneumococcal 13-valent conjugate vaccine [diphtheria CRM197 protein]) as a single-dose for adults.

August 16, 2011

Pharmaca Integrative Pharmacy on Tuesday announced that it is now offering immunizations for influenza, pneumonia and whooping cough on a walk-in basis.

BOULDER, Colo. — Pharmaca Integrative Pharmacy on Tuesday announced that it is now offering immunizations for influenza, pneumonia and whooping cough on a walk-in basis. The majority of Pharmaca’s pharmacists are trained to provide the shots to any customer who requests one during open pharmacy hours.

In addition, Pharmaca will hold Flu Shot Clinics every Tuesday in September, October and November, between 2 p.m. and 6 p.m.

April 21, 2011

Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

WHITEHOUSE STATION, N.J. — Merck and Sanofi Pasteur have started a late-stage clinical trial of a combination vaccine for six childhood diseases, the companies said Thursday.

January 27, 2011

Seniors of Hispanic descent are far less likely to become immunized against the flu or pneumonia, compared with white seniors, according to a new RAND study released earlier this week.

SANTA MONICA, Calif. — Seniors of Hispanic descent are far less likely to become immunized against the flu or pneumonia, compared with white seniors, according to a new RAND study released earlier this week.

Researchers found that Hispanic seniors who prefer speaking Spanish and live in such linguistically isolated communities as the Southeast are least likely to be immunized.

October 31, 2010

The Food and Drug Administration has approved a new treatment for bacterial infections made by...

NEW YORK The Food and Drug Administration has approved a new treatment for bacterial infections made by Forest Labs, Forest said.

The drug maker announced the approval of Teflaro (ceftaroline fosamil) for the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection, also known as ABSSSI, caused by bacteria that include methicillin-resistant Staphylococcus aureaus.

October 10, 2010

Humanity has come a long way since the days when people thought sickness came from...

September 16, 2010

Drug-resistant bacterial infections recently have been reported in more than 20 states across the United...

August 19, 2010

An anti-inflammatory drug approved 60 years ago may help fight against a fungal infection of...

March 17, 2010

A phase-3 clinical trial found that a pneumococcal disease vaccine was well-tolerated and immunogenic in...

February 23, 2010

The Food and Drug Administration has approved a vaccine for preventing pneumococcal disease in children,...

October 6, 2008

Nearly 1,300 Rite Aid pharmacies will offer a one-day flu clinic on October 21, 22...

CAMP HILL, Pa. Nearly 1,300 Rite Aid pharmacies will offer a one-day flu clinic on October 21, 22 or 23, the drug chain announced Monday. Flu shots are available at no cost for patients with Medicare Part B health coverage and $30 for all other patients; pneumonia shots are available for $45.